Jay Reeder
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Urinary Bladder Neoplasms | 19 | 1986 | 44 |
Why?
| Disease Models, Animal | 4 | 2008 | 349 |
Why?
| DNA, Neoplasm | 9 | 1988 | 75 |
Why?
| Thrombospondin 1 | 2 | 2005 | 8 |
Why?
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2010 | 5 |
Why?
| Androgens | 3 | 2006 | 38 |
Why?
| Urologic Diseases | 1 | 2009 | 14 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2004 | 58 |
Why?
| Meningioma | 1 | 2010 | 26 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2004 | 67 |
Why?
| Diabetes Complications | 1 | 2009 | 49 |
Why?
| Cell Proliferation | 2 | 2008 | 227 |
Why?
| Cystocele | 1 | 2008 | 3 |
Why?
| Diabetes Mellitus | 1 | 2009 | 72 |
Why?
| Uterine Prolapse | 1 | 2008 | 8 |
Why?
| Prostatic Neoplasms | 4 | 2005 | 120 |
Why?
| Image Cytometry | 2 | 1997 | 6 |
Why?
| Neoplasms, Experimental | 1 | 2008 | 72 |
Why?
| Flow Cytometry | 12 | 1986 | 216 |
Why?
| Tumor Suppressor Proteins | 3 | 2002 | 51 |
Why?
| Brain Neoplasms | 1 | 2010 | 116 |
Why?
| In Situ Hybridization, Fluorescence | 5 | 1994 | 53 |
Why?
| Receptors, Interleukin-8A | 1 | 2005 | 4 |
Why?
| Receptors, Interleukin-8B | 1 | 2005 | 10 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2005 | 9 |
Why?
| Mice, Transgenic | 4 | 2006 | 209 |
Why?
| Chromosomes, Human, Pair 9 | 4 | 1994 | 10 |
Why?
| Interleukin-8 | 1 | 2005 | 54 |
Why?
| Sphingomyelin Phosphodiesterase | 1 | 2002 | 9 |
Why?
| Signal Transduction | 3 | 2004 | 313 |
Why?
| Mice | 6 | 2002 | 623 |
Why?
| Chromosome Aberrations | 2 | 1994 | 45 |
Why?
| Male | 15 | 1994 | 1553 |
Why?
| Apoptosis | 2 | 2004 | 265 |
Why?
| Genes, p16 | 1 | 1997 | 10 |
Why?
| Animals | 7 | 2002 | 1031 |
Why?
| Urothelium | 2 | 2006 | 15 |
Why?
| Urinary Bladder | 5 | 1988 | 37 |
Why?
| Female | 17 | 1986 | 1643 |
Why?
| Blotting, Western | 3 | 2002 | 275 |
Why?
| Epithelial Cells | 4 | 2004 | 135 |
Why?
| Cystitis, Interstitial | 2 | 2004 | 11 |
Why?
| DNA | 5 | 1988 | 262 |
Why?
| Carcinoma, Transitional Cell | 4 | 1988 | 24 |
Why?
| Tomography, X-Ray Computed | 2 | 2008 | 321 |
Why?
| Humans | 29 | 1986 | 1856 |
Why?
| Cell Cycle | 2 | 2004 | 121 |
Why?
| Therapeutic Irrigation | 6 | 1988 | 30 |
Why?
| Aged, 80 and over | 4 | 1994 | 599 |
Why?
| Prothrombin | 1 | 2011 | 6 |
Why?
| Immunohistochemistry | 4 | 2003 | 355 |
Why?
| STAT3 Transcription Factor | 1 | 2010 | 19 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2005 | 126 |
Why?
| World Health Organization | 1 | 2010 | 19 |
Why?
| Meningeal Neoplasms | 1 | 2010 | 30 |
Why?
| Thrombin | 1 | 2011 | 41 |
Why?
| Point Mutation | 1 | 2010 | 122 |
Why?
| Middle Aged | 6 | 1994 | 1161 |
Why?
| Neoplasm Recurrence, Local | 2 | 1999 | 118 |
Why?
| Prostate | 1 | 2011 | 55 |
Why?
| Pelvis | 1 | 2008 | 38 |
Why?
| Antigens, Polyomavirus Transforming | 1 | 2008 | 18 |
Why?
| Pregnancy, Animal | 1 | 2008 | 20 |
Why?
| Orchiectomy | 1 | 2008 | 23 |
Why?
| Pedigree | 1 | 2008 | 84 |
Why?
| Cell Line, Tumor | 3 | 2004 | 208 |
Why?
| Parity | 1 | 2008 | 28 |
Why?
| Aged | 5 | 1994 | 988 |
Why?
| Calcitriol | 1 | 2007 | 29 |
Why?
| Early Diagnosis | 1 | 2006 | 23 |
Why?
| Genes, Tumor Suppressor | 2 | 2002 | 37 |
Why?
| Neurosecretory Systems | 1 | 2006 | 18 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2006 | 27 |
Why?
| Genital Diseases, Female | 1 | 1986 | 22 |
Why?
| Transfection | 3 | 2002 | 237 |
Why?
| Obesity | 1 | 2009 | 149 |
Why?
| Tumor Cells, Cultured | 4 | 1989 | 233 |
Why?
| Phenotype | 1 | 2008 | 303 |
Why?
| Antigens, Thy-1 | 1 | 2005 | 22 |
Why?
| Analysis of Variance | 3 | 1991 | 339 |
Why?
| Mammary Glands, Human | 1 | 2004 | 7 |
Why?
| Up-Regulation | 2 | 2002 | 183 |
Why?
| Ovarian Neoplasms | 1 | 2005 | 64 |
Why?
| NIH 3T3 Cells | 1 | 2004 | 22 |
Why?
| Fibronectins | 1 | 2005 | 57 |
Why?
| Growth Inhibitors | 1 | 2004 | 33 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 65 |
Why?
| Caspase 3 | 1 | 2004 | 56 |
Why?
| Epidermal Growth Factor | 1 | 2004 | 51 |
Why?
| Caspases | 1 | 2004 | 58 |
Why?
| Sequence Analysis, Protein | 1 | 2002 | 14 |
Why?
| Vaginal Smears | 3 | 1986 | 31 |
Why?
| 3T3 Cells | 1 | 2002 | 54 |
Why?
| Two-Hybrid System Techniques | 1 | 2002 | 42 |
Why?
| Gene Expression | 2 | 2002 | 291 |
Why?
| Pregnancy | 1 | 2008 | 455 |
Why?
| Magnetic Resonance Imaging | 1 | 2008 | 294 |
Why?
| Blotting, Northern | 1 | 2002 | 151 |
Why?
| Cell Cycle Proteins | 1 | 2004 | 71 |
Why?
| Adult | 5 | 1994 | 1317 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 113 |
Why?
| Protein-Serine-Threonine Kinases | 1 | 2004 | 105 |
Why?
| Reproducibility of Results | 2 | 1991 | 391 |
Why?
| Monosomy | 1 | 1999 | 4 |
Why?
| RNA, Messenger | 2 | 2002 | 394 |
Why?
| Protein Binding | 1 | 2002 | 256 |
Why?
| Cytodiagnosis | 2 | 1986 | 17 |
Why?
| Cell Nucleus | 2 | 1990 | 169 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 1994 | 5 |
Why?
| Cell Line | 3 | 1989 | 375 |
Why?
| Sensitivity and Specificity | 1 | 1998 | 427 |
Why?
| Specimen Handling | 3 | 1986 | 52 |
Why?
| Acridine Orange | 2 | 1986 | 8 |
Why?
| Fixatives | 2 | 1989 | 13 |
Why?
| Lymphocytes | 2 | 1989 | 142 |
Why?
| Tissue Array Analysis | 1 | 2011 | 27 |
Why?
| Stromal Cells | 1 | 2011 | 41 |
Why?
| Uterine Cervical Diseases | 1 | 1990 | 10 |
Why?
| In Situ Hybridization | 1 | 2011 | 135 |
Why?
| Fluorescence | 1 | 1989 | 46 |
Why?
| Statistics as Topic | 2 | 1986 | 133 |
Why?
| Algorithms | 2 | 1988 | 226 |
Why?
| Ethanol | 1 | 1989 | 58 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 279 |
Why?
| Mycobacterium bovis | 1 | 2007 | 7 |
Why?
| Administration, Intravesical | 1 | 2007 | 17 |
Why?
| Receptors, Calcitriol | 1 | 2007 | 15 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 10 |
Why?
| Models, Theoretical | 1 | 1987 | 124 |
Why?
| Chromosomes, Human, Pair 17 | 2 | 1994 | 14 |
Why?
| Evaluation Studies as Topic | 1 | 1986 | 178 |
Why?
| Staining and Labeling | 1 | 1986 | 101 |
Why?
| Diagnostic Errors | 1 | 1986 | 73 |
Why?
| Doxycycline | 1 | 2005 | 34 |
Why?
| Double-Blind Method | 1 | 2007 | 274 |
Why?
| Biological Markers | 1 | 2007 | 262 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 24 |
Why?
| Feedback, Physiological | 1 | 2004 | 26 |
Why?
| Ploidies | 1 | 2004 | 20 |
Why?
| Retinoblastoma Protein | 1 | 2004 | 26 |
Why?
| Cell Division | 1 | 2006 | 273 |
Why?
| Receptor, Epidermal Growth Factor | 1 | 2004 | 54 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 243 |
Why?
| Cell Communication | 1 | 2004 | 72 |
Why?
| Prospective Studies | 1 | 2007 | 545 |
Why?
| Enzyme Activation | 1 | 2004 | 177 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2003 | 82 |
Why?
| Longitudinal Studies | 1 | 2003 | 195 |
Why?
| Antineoplastic Agents | 1 | 2007 | 190 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 216 |
Why?
| Phosphorylation | 1 | 2004 | 224 |
Why?
| Disease Progression | 1 | 2003 | 244 |
Why?
| Aneuploidy | 2 | 1989 | 15 |
Why?
| Cell Differentiation | 1 | 2006 | 262 |
Why?
| Reference Standards | 2 | 1989 | 35 |
Why?
| Time Factors | 1 | 2005 | 896 |
Why?
| Predictive Value of Tests | 1 | 1999 | 321 |
Why?
| Cell Count | 2 | 1986 | 163 |
Why?
| Laboratories | 1 | 1996 | 21 |
Why?
| Probability | 2 | 1987 | 190 |
Why?
| Retrospective Studies | 1 | 2003 | 653 |
Why?
| Data Interpretation, Statistical | 1 | 1996 | 109 |
Why?
| Chi-Square Distribution | 1 | 1996 | 179 |
Why?
| Interphase | 1 | 1994 | 26 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 1994 | 21 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 1994 | 19 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 1994 | 19 |
Why?
| Epithelium | 1 | 1991 | 101 |
Why?
| Base Sequence | 1 | 1994 | 371 |
Why?
| Precancerous Conditions | 1 | 1990 | 29 |
Why?
| Interinstitutional Relations | 1 | 1989 | 12 |
Why?
| Tissue Preservation | 1 | 1989 | 16 |
Why?
| Quality Control | 1 | 1989 | 54 |
Why?
| Automatic Data Processing | 1 | 1988 | 7 |
Why?
| National Institutes of Health (U.S.) | 1 | 1989 | 45 |
Why?
| Molecular Sequence Data | 1 | 1994 | 404 |
Why?
| Uterine Cervical Neoplasms | 1 | 1990 | 55 |
Why?
| Cell Separation | 1 | 1989 | 110 |
Why?
| Pilot Projects | 1 | 1989 | 264 |
Why?
| False Negative Reactions | 1 | 1987 | 53 |
Why?
| False Positive Reactions | 1 | 1987 | 71 |
Why?
| Cervix Uteri | 1 | 1987 | 38 |
Why?
| Diagnosis, Differential | 1 | 1990 | 402 |
Why?
| Child | 1 | 1994 | 749 |
Why?
| Uterine Neoplasms | 1 | 1986 | 52 |
Why?
| United States | 1 | 1989 | 604 |
Why?
|
|
Reeder's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
